Dr. Vipin Valam Puthussery 

Awards

• Presidents NBE Gold Medal for all India First rank in DNB Endocrinology 2015
• Gold medal and best outgoing student – MD General Medicine 2011 – Govt. Medical College Trivandrum
• First rank – Kerala University, MD general medicine, 2011
• Second rank final year MBBS, Calicut University 2006
• Best outgoing student – 2006, Govt. Medical College Calicut
• IMA Gold medal – best outgoing student 45th Batch Calicut Medical college – 2007
• Gold Medals during MBBS – Community medicine, Psychiatry, General medicine, Surgery, Obstetrics and Gynecology
• ESICON – Endocrinology quiz – First prize 2010 (CMC Vellore)
• Cleared MOH exam – Oman, Got Practicing License

Fields of Special Interest

Diabetes mellitus especially type 1, PCOS, Obesity, metabolic bone disorders and pituitary diseases

Languages Known

English, Hindi, Malayalam

Recent Conferences Attended

International

• AACE conference 2017 – Austin Texas
• AACE – 2018 – Boston, USA

National

• ESICON 2016 – New, Delhi
• ESICON 2017, Trivandrum, Kerala
• APICON – 2019, Kochi
• ISBMR – 2014 Lucknow

Memberships

• ESI – Endocrine society of India
• AACE – American association of Clinical Endocrinologists
• Endo society
• ISPAD – Indian society of pediatric and adolescent endocrinology
• Royal college of Physicians
• PACE – Professional Association of Clinical Endocrinologists – Kerala

Departmental Activities

• Started the department in Aster Medcity in October 2015
• Number of OPs seen per day – 35-40
• Number of IP consultations seen per day – 25-30
• Number of admissions – 1-3 /week
• Made Diabetic monitoring chart with insulin correction doses – for inpatients, for patients on enteral feeds
• Made insulin infusion protocols along with ICU team – for DKA, HSS, Hyperglycemia
• Made Diabetic Education material for Inpatients and out patients
• Conducted Aster Endo summit 2017, 2018, 2019 – with a grand success (along with Endo team)

Research Experience

Clinical Trials

• A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study to Evaluate Efficacy and Safety of TRC150094 as an Add on to Standard of Care in Improving Cardiovascular Risk in Subjects with Diabetes, Dyslipidemia and Hypertension – Co Investigator (On Going)
• A 26-week Randomized Open-label, Parallel group Comparison of SAR341402 Mix 70/30 to Novomix 30 in Adult Patients with Diabetes Mellitus using Pre-mixe Insulin Analogs – Principal investigator (On Going)
• An Indian multi-centre, prospective, open-label, single-arm, non-interventional, post marketing surveillance study of Fiasp® to evaluate safety and effectiveness in patients with diabetes mellitus in routine clinical practice- Study Number: NN1218-4489 – Principal Investigator (ongoing)

Other research Experience

Dissertation: “Prevalence of diabetic peripheral neuropathy in rural Trivandrum – a community-based study” for the degree of Doctor of Medicine, in General Medicine under University of Kerala.

Projects

• “Cardiovascular disease risk assessment in parents of women with PCOS” for degree of Doctorate of Medicine in Endocrinology under SGPGIMS, Lucknow with Dr Preeti Dabadghao (Associate Professor, Endocrinology, SGPGIMS).
• “Prevalence and clinical significance of ZnT8A in young North Indian Type 1 Diabetes mellitus patients” for degree of Doctorate of Medicine in Endocrinology under SGPGIMS, Lucknow with Dr Eesh Bhatia (Professor and Head, Endocrinology, SGPGIMS)

Papers and Posters

• ISPAD 2018 Poster – Low prevalence of Islet Antibody negative type 1 diabetes mellitus among children and adolescents in north India.
• ESICON 2015, Chandigarh – Oral presentation – “Frequency of ZnT8A in Indian type 1 diabetes patients”
• ESICON 2015, Chandigarh – Poster presentation – ‘Cardiovascular disease risk assessment in parents of PCOS patients”

Publications

• Fertil Steril. 2016 May;105(5):1338-1344.e3. doi: 10.1016/j.fertnstert.2016.01.024. Epub 2016 Feb 4. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome. Vipin VP1, Dabadghao P2, Shukla M1, Kapoor A3, Raghuvanshi AS3, Ramesh V4. www.ncbi.nlm.nih.gov/pubmed/26852421
• Hum Reprod. 2019 Jul 12. pii: dez104. doi: 10.1093/humrep/dez104. [Epub ahead of print] Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Karthik S1, Vipin VP2, Kapoor A3, Tripathi A4, Shukla M4, Dabadghao P4.
• Indian J Med Res 149, April 2019, pp 479-488 Heterogeneity in the aetiology of diabetes mellitus in young adults: A prospective study from north India Sahoo Saroj Kumar, Zaidi Ghazala, Vipin Valam Puthussery, Chapla Aaron, Thomas Nihal, Yu Liping, Asthana Pranjul, Bhatia Eesh . Year : 2019 | Volume: 149 | Issue Number: 4 | Page: 479-488
• Low prevalence of Islet Antibody negative type 1 diabetes mellitus among children and adolescents in north India. First author – under review for publication in Pediatric diabetes
• John G, Asghari M, Vipin VP, Eapen V. (2019). Depression and Metabolic Syndrome: Two Sides of the Same Coin. J Biomed Sci Res1(2): 109
• Technological Advances in the Treatment of Type 1 Diabetes – Book review, Vipin V P and Eesh Bhatia. November 2015. The National medical journal of India 28(2):103
• “Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method“. Sunil M Jain; K Seshadri; AG Unnikrishnan; M Chawla; P Kalra; VP Vipin; E Ravishankar; J Chordia; S Das; J Wazir; SM Bandookwala; N Deka; G Agarwal; VG Kumar; S Erande –Diabetes Ther

Other Major Presentations

• Insulin workshop – Starting insulin treatment in a patient with Type 2 Diabetes: Case based discussion – APICON 2019, Kochi
• Application of newer technologies in the management of Diabetes mellitus – IMA state chapter – Pala 2018
• Statin Induced diabetes – Hype or Fact? – RSSDI regional chapter – Thiruvalla 2018
• Acute metabolic complications of Diabetes – Indian institute of Diabetes 2018, Trivandrum
• Adrenal Fatigue, Maternal supplementation of Vitamin D and neonatal outcome – KENDOCON 2019

Other Disclosures

• Advisory board member for Novo Nordisk, Sanofi and Lupin diabetes division
• Give talks for Major Pharmaceutical companies like Novo Nordisk, Lilly, Novartis, MSD, Boehringer Ingelheim, Sanofi and Abott.